# Vertex Pharmaceuticals Incorporated - Inspection Records

Source: https://www.keypedia.com/companies/vertex-pharmaceuticals-incorporated/f2bc62b8-1ece-42d2-b058-39466a256c74

> Inspection records and compliance data for Vertex Pharmaceuticals Incorporated in Boston, Massachusetts. Access full analysis and detailed observations.

---

## Details

- Name: Vertex Pharmaceuticals Incorporated
- FEI Number: 1000513211
- City: Boston
- State: Massachusetts
- Country Name: United States
- Address Line 1: 50 Northern Ave
- Zip Code: 02210

## Related Documents

- [FDA Inspection 1306258 - Vertex Pharmaceuticals Incorporated - 2026-03-03](https://www.keypedia.com/records/fda_inspections/vertex-pharmaceuticals-incorporated/39438762-62e2-4992-8b2c-9619e8660021) — source: FDA, date: March 3, 2026
- [FDA Inspection 1306258 - Vertex Pharmaceuticals Incorporated - 2026-03-03](https://www.keypedia.com/records/fda_inspections/vertex-pharmaceuticals-incorporated/bc146f43-1e81-4339-a15b-d826e903c323) — classification: No Action Indicated (NAI), source: FDA, date: March 3, 2026
- [FDA Inspection 1246447 - Vertex Pharmaceuticals Incorporated - 2024-08-01](https://www.keypedia.com/records/fda_inspections/vertex-pharmaceuticals-incorporated/c4ab424b-474e-495d-9305-8ea1aaab2658) — classification: No Action Indicated (NAI), source: FDA, date: August 1, 2024
- [483 - Vertex Pharmaceuticals Incorporated - 2023-05-04](https://www.keypedia.com/records/483/vertex-pharmaceuticals-incorporated/5261a188-7e21-4926-88da-807f338c3960) — source: FDA, date: May 4, 2023
- [FDA Inspection 1205834 - Vertex Pharmaceuticals Incorporated - 2023-05-04](https://www.keypedia.com/records/fda_inspections/vertex-pharmaceuticals-incorporated/4cbf0acd-6531-444b-9f0e-e38d042a7300) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 4, 2023
- [FDA Inspection 1180001 - Vertex Pharmaceuticals Incorporated - 2022-08-19](https://www.keypedia.com/records/fda_inspections/vertex-pharmaceuticals-incorporated/2a08f2c0-64e1-485c-b0c0-b743e6cc1e54) — classification: No Action Indicated (NAI), source: FDA, date: August 19, 2022
- [FDA Inspection 1029564 - Vertex Pharmaceuticals Incorporated - 2017-10-05](https://www.keypedia.com/records/fda_inspections/vertex-pharmaceuticals-incorporated/ef449ae2-6306-4b62-a369-7b0b42a98023) — classification: No Action Indicated (NAI), source: FDA, date: October 5, 2017
- [FDA Inspection 988733 - Vertex Pharmaceuticals Incorporated - 2016-09-21](https://www.keypedia.com/records/fda_inspections/vertex-pharmaceuticals-incorporated/7baeff73-fdc6-4de1-a6ea-022969fc8028) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 21, 2016
- [EIR - Vertex Pharmaceuticals Incorporated - 2015-04-29](https://www.keypedia.com/records/eir/vertex-pharmaceuticals-incorporated/8aaf0ef4-6ad9-43e4-8420-e0fc60e81a1f) — source: FDA, date: April 29, 2015
- [FDA Inspection 926154 - Vertex Pharmaceuticals Incorporated - 2015-04-29](https://www.keypedia.com/records/fda_inspections/vertex-pharmaceuticals-incorporated/c9d0f7be-c837-48e7-9689-03fbb3fb360d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 29, 2015
- [FDA Inspection 916736 - Vertex Pharmaceuticals Incorporated - 2015-02-17](https://www.keypedia.com/records/fda_inspections/vertex-pharmaceuticals-incorporated/cb597169-8f34-4c11-8171-0a7eac42ae89) — classification: No Action Indicated (NAI), source: FDA, date: February 17, 2015
- [FDA Inspection 902520 - Vertex Pharmaceuticals Incorporated - 2014-10-16](https://www.keypedia.com/records/fda_inspections/vertex-pharmaceuticals-incorporated/3c55544b-fd12-4239-9caa-59a431d5894f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 16, 2014

## Related Companies

- [AustarPharma, LLC](https://www.keypedia.com/companies/austarpharma-llc/05a402ea-dcb1-4900-9553-0a3a1b908183)
- [Oncotec Pharma Produktion GmbH](https://www.keypedia.com/companies/oncotec-pharma-produktion-gmbh/7789d312-a14f-4f62-93df-246fa5e3d350)
- [Zydus Lifesciences Limited](https://www.keypedia.com/companies/zydus-lifesciences-limited/1001ec04-226a-40ff-8f30-2b3b2f34b359)
- [LTS Therapy Systems, LLC](https://www.keypedia.com/companies/lts-therapy-systems-llc/2bbbf391-d6c1-4789-a5da-63a32fda9b30)
- [Blistex Inc](https://www.keypedia.com/companies/blistex-inc/5268fd01-ac61-4bf8-a1ca-192da45c825a)
- [Towa Pharmaceutical Europe, S.L.](https://www.keypedia.com/companies/towa-pharmaceutical-europe-sl/731d0b47-ce02-4781-8582-7090b456c5fe)
- [J. B. Chemicals and Pharmaceuticals Limited](https://www.keypedia.com/companies/j-b-chemicals-and-pharmaceuticals-limited/d77ff966-bfe4-483b-8ca9-723a59fcaba5)
- [Noven Pharmaceuticals Inc](https://www.keypedia.com/companies/noven-pharmaceuticals-inc/78cbceb0-5494-46a4-be87-8acf4450fa52)
- [Alkermes Inc](https://www.keypedia.com/companies/alkermes-inc/c20f3273-400d-4b2e-a485-214b986ed7c2)
- [ZYDUS LIFESCIENCES LIMITED](https://www.keypedia.com/companies/zydus-lifesciences-limited/aa40e2a7-c250-4524-b05f-6ca311474c5c)

## Related Officers

- [Consumer Safety Officer](https://www.keypedia.com/people/arie-c-menachem/01bacbef-a3ae-4eb0-a56f-e8a70b67a524)
- [company_representative](https://www.keypedia.com/people/laura-hoffman/20857273-6951-4927-ae94-91a91313ce9b)
- [Robert J. Martin](https://www.keypedia.com/people/robert-j-martin/8bd5c75a-ec53-4ae5-9739-a39489686cae)